CLASS II ONGOING Device recall · Reported 27 Nov 2024 · FDA Enforcement Report

cobas HCYS, Homocysteine Enzymatic Assay, Material Number recalled

Roche Diagnostics Operations is recalling cobas HCYS, Homocysteine Enzymatic Assay, Material Number, distributed in 8 states. The recall was initiated on 17 Oct 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 04015630929979, Lot Number 747029, exp. 30-SEPT-2024
Quantity recalled458 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0489-2025
FDA event ID
95609
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Ongoing
Recall initiated
17 Oct 2024
FDA classified
19 Nov 2024
Reported
27 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

17 Oct 2024Recall initiated by company
19 Nov 2024Classified by FDA+33 days
27 Nov 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine

Where it was distributed

US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,

FloridaIowaIndianaNew JerseyNew YorkOklahomaSouth CarolinaTexas

Questions about this recall

Why was it recalled?

Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)

Which lots are affected?

UDI/DI 04015630929979, Lot Number 747029, exp. 30-SEPT-2024

Where was it sold?

US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Test Kits & Diagnostics recalls

All 2,663